针对 PD-L1 的定向进化驱动的重新编程,用于紧和可调节的检查点调制
Ji Yeon Ha1,2, Dongwoo Kim3, Petrina Jebamani4
1Department of Biomedical Sciences, Graduate School, Korea University, Seoul, 02707, Republic of Korea.
Journal of biological engineering
|December 5, 2025
概括
研究人员设计了一种新的PD-L1变体,具有增强的PD-1结合,为癌症免疫疗法开发提供了更有效和更适应的平台.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 合成生物学 合成生物学
背景情况:
- 针对PD-1/PD-L1轴的免疫检查点抑制剂 (ICI) 是成功的癌症疗法.
- 目前基于IgG的ICI的局限性包括瘤透率低下和T细胞枯竭.
- 需要替代蛋白质支架来改善PD-1/PD-L1向.
研究的目的:
- 开发一个紧和可调节的PD-L1变体,具有高亲和度PD-1结合.
- 为了设计一种基于连接体的检查点抑制剂,提高治疗潜力.
- 克服现有的基于IgG的检查点抑制剂的局限性.
主要方法:
- 基于酵母表面显示的定向进化被用来产生PD-L1变体.
- 一个变异的PD-L1ectodomain库被选为高亲和度结合剂.
- 进行了in silico免疫性分析和结构建模.
主要成果:
- 开发了一种双重突变 (DM) PD-L1 变种,具有173倍增强的PD-1 结合.
- 这种DM变种显示出预测的免疫性较低,与野生类型PD-L1.1相当.
- 功能性测试证实恢复的T细胞活性与增加的细胞因子分泌.
结论:
- 定向进化成功地产生了一种高亲和度,低免疫性PD-L1变种.
- 工程DM变体为下一代免疫疗法提供了一个多功能平台.
- 这种方法扩大了基于连接体的检查点抑制剂的设计空间.
相关概念视频
Conservative Site-specific Recombination and Phase Variation
6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.6K
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K


